European Court of Justice finds “irregularities” in Pfizer deal; says Commission president did not have sufficient reason to withhold details from public.
An advisory body for the Council of Europe has come out strongly against the law, noting that its approval this close to Poland’s general elections this fall would create an uneven playing field.
We use cookies to enhance your browsing experience and to personalize the content and advertisements that you see on our website. AcceptDeclinePrivacy policy
